COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis (Q62104975)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis |
clinical trial |
Statements
A Phase III, 12-Week, Multicentre, Double-Blind, Randomised, Placebo- and Active Comparator-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381, 5mg, 10mg, 25mg, and 50mg Administered Orally Once Daily, in Adults With Rheumatoid Arthritis (English)
0 references
June 2005
0 references
September 2006
0 references
2,208
0 references